Cited by 979Telomeres, Telomerase, and SenescenceCancer-related Molecular PathwaysGenetics, Aging, and Longevity in Model Organisms

p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis

Open access
Chin, Lynda, Artandi, Steven E, Shen, Qiong, Tam, Alice, Lee, Shwu-Luan, Gottlieb, Geoffrey J, Greider, Carol W, DePinho, Ronald A·1999·Cell

Abstract

Maintenance of telomere length and function is critical for the efficient proliferation of eukaryotic cells. Here, we examine the interactions between telomere dysfunction and p53 in cells and organs of telomerase-deficient mice. Coincident with severe telomere shortening and associated genomic instability, p53 is activated, leading to growth arrest and/or apoptosis. Deletion of p53 significantly attenuated the adverse cellular and organismal effects of telomere dysfunction, but only during the earliest stages of genetic crisis. Correspondingly, the loss of telomere function and p53 deficiency cooperated to initiate the transformation process. Together, these studies establish a key role for p53 in the cellular response to telomere dysfunction in both normal and neoplastic cells, question the significance of crisis as a tumor suppressor mechanism, and identify a biologically relevant stage of advanced crisis, termed genetic catastrophe.

Verified 2026-10-06 · 12 references not checked yet

AI snapshot

Written from the paper’s full text.

TL;DR

In telomerase-deficient (mTR−/−) mice, critically short telomeres activate p53, and deleting p53 rescues the resulting apoptosis and cell-cycle arrest — but only during early "crisis." Loss of telomere function and p53 deficiency cooperate to initiate transformation, while telomerase reconstitution mainly benefits later stages of tumorigenesis.

Key findings

  • Critical telomere shortening activates p53: p53 protein was detectable in G6 mTR−/− testis but not in mTR+/+ or G6 mTR−/− p53−/− littermates; >80% of G4 and G6 MEFs stained positive for p53 at passage 6 versus 21% of mTR+/+ MEFs. p21CIP1/WAF1 rose 3- to 4-fold in G6 versus G2 mTR−/− p53+/+ MEFs, and p53-dependent CAT reporter activity increased ~2-fold.
  • p53 loss rescued telomere-dysfunction phenotypes early but not late: 15% of G4–G6 mTR−/− mice (86/565) were p53−/− versus 26% of G7–G8 mice (24/91) (p = 0.015); all G5 mTR−/− p53−/− testes had normal histology, but 3 of 7 G6 and all five G7–G8 samples showed germ cell depletion. G6 mTR−/− p53−/− MEFs showed a 3-fold increase in chromosome fusions (1.65, SD 2.59 vs 0.42, SD 0.71 per metaphase; p = 0.012), with no change in telomere length (75% reduction regardless of p53 status).
  • Telomere dysfunction cooperated with p53 deficiency to initiate transformation: adding mTR suppressed Myc/RAS focus formation in G6 mTR−/− p53−/− MEFs, but mTR-transfected foci had higher subcloning efficiency (23/26, 89%) than vector foci (19/32, 59%; p = 0.018). Tumor formation in SCID mice was similar between groups.
  • The authors propose dividing crisis into p53-dependent "early crisis" and p53-independent "genetic catastrophe," questioning crisis as a tumor suppressor mechanism.

Methods

  • Mouse genetics: mTR+/− mice crossed with p53+/− mice to generate successive generations (G1–G8) of mTR−/− animals with p53+/+, +/−, and −/− genotypes in a mixed WW6/C57BL/6 background; p53 status maintained heterozygous during matings.
  • Cellular/organ assays: immunoblotting and immunohistochemistry for p53 and p21, pG13CAT reporter assays, testis histology with TUNEL, BrdU/propidium iodide FACS cell-cycle profiles, flow FISH telomere length, and metaphase spreads for chromosome fusions.
  • Transformation assays: Myc/RAS cotransfection of early-passage MEFs with empty vector or an mTR genomic fragment, scoring focus formation, subcloning efficiency, and tumor formation after subcutaneous injection into SCID mice.

Limitations

  • Stated: the mechanisms by which tumorigenic potential is maintained in late stages of tumorigenesis despite telomere dysfunction "remain to be determined"; whether loss of TRF2 binding, short telomeres, or fusion-bridge-breakage cycles mediate the p53 induction described also remains undetermined.
  • Evident from the text: the G7–G8 genotype comparison rests on small numbers (24 of 91 mice), and all mice are in a mixed genetic background, which the authors note required cousin mating to avoid substrains.
  • Evident from the text: the transformation data are from cultured MEFs and SCID xenografts, and tumor weights/efficiency between mTR and vector lines were not significantly different, so the in vivo relevance of the initiation advantage is inferred rather than directly demonstrated.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(00)80762-x

Cites

32 of 44 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 37 cited sources checked · 0 supported · 0 flagged

  • Findingreasoning
    § Abstract

    Loss of telomere function and p53 deficiency cooperated to initiate the transformation process.

    “Correspondingly, the loss of telomere function and p53 deficiency cooperated to initiate the transformation process.”
    Quote in the paperSubstantial claim
  • Findingnone given
    § Abstract

    Coincident with severe telomere shortening and associated genomic instability, p53 is activated, leading to growth arrest and/or apoptosis.

    “Coincident with severe telomere shortening and associated genomic instability, p53 is activated, leading to growth arrest and/or apoptosis.”
    Quote in the paperSubstantial claim
  • Findingown data
    § Abstract

    CAT activity was strictly dependent upon p53.

    “This activity was strictly dependent upon p53, since p53−/− and G6 mTR−/− p53−/− MEF cultures showed only background levels of CAT activity.”
    Quote in the paperSubstantial claim
  • Findingown data
    § Abstract

    p53 mediates the adverse effects of critically shortened telomeres.

    “We found that p53 mediates the adverse effects of critically shortened telomeres.”
    Quote in the paperSubstantial claim
  • Findingown data
    § Abstract

    DNA content analyses of G6 mTR−/− p53+/+ MEFs revealed a profile consistent with a biphasic block as evidenced by marked accumulation of cells in G1 and G2/M phases.

    “As shown in Figure 3A, DNA content analyses of G6 mTR−/− p53+/+ MEFs revealed a profile consistent with a biphasic block as evidenced by marked accumulation of cells in G1 and G2/M phases.”
    Quote in the paperSubstantial claim
  • May combine two claims. 36
  • The quote only partly states this claim. 1
  • Classified as probably not a substantial claim. 16
  • May combine two claims.

    Findingown data
    § Abstract

    Deletion of p53 significantly attenuated the adverse cellular and organismal effects of telomere dysfunction, but only during the earliest stages of genetic crisis.

    “Deletion of p53 significantly attenuated the adverse cellular and organismal effects of telomere dysfunction, but only during the earliest stages of genetic crisis.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data
    § Abstract

    mTR+/+ p53+/+ MEF cultures demonstrated 35% of cells in S phase and only 13% in G2/M.

    “In contrast, mTR+/+ p53+/+ MEF cultures demonstrated 35% of cells in S phase and only 13% in G2/M.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data
    § Abstract

    In mTR+/+ testis, p53 status did not affect testicular volume or significantly alter the cytoarchitecture of seminiferous tubules.

    “In mTR+/+ testis, p53 status did not affect testicular volume or significantly alter the cytoarchitecture of seminiferous tubules (Figure 2A and Figure 2B).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data
    § Abstract

    Only 21% of mTR+/+ MEFs at passage 6 stained positive for p53, whereas more than 80% of MEFs derived from G4 and G6 exhibited strong immunoreactivity to p53.

    “Whereas only 21% of the mTR+/+ MEFs at passage 6 stained positive for p53, more than 80% of MEFs derived from G4 and G6 exhibited strong immunoreactivity to p53 (Figure 1B, compare [a] with [b] and [c]).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingreasoning
    § Discussion

    In male germ cells and lymphocytes, telomere loss elicits a strong apoptotic response, whereas MEFs experience a potent biphasic cell cycle block.

    “In male germ cells and lymphocytes, telomere loss elicits a strong apoptotic response, whereas MEFs experience a potent biphasic cell cycle block.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.
  • May combine two claims.

    Findingown data
    § Abstract

    All G5 mTR−/− p53−/− testes exhibited normal histology, while 3 of 7 G6 mTR−/− p53−/− samples still showed varying degrees of pathology.

    “Whereas all G5 mTR−/− p53−/− testes exhibited normal histology, 3 of 7 G6 mTR−/− p53−/− samples still showed varying degrees of pathology (Table 1).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data
    § Abstract

    BrdU incorporation assay showed that 36% of G6 mTR−/− p53+/+ cells were in G1 phase, 3% were in S phase, and 40% were in G2/M.

    “Accordingly, BrdU incorporation assay showed that 36% of the G6 mTR−/− p53+/+ cells were in G1 phase, 3% were in S phase, and 40% were in G2/M (Figure 3A, top panel).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data
    § Results

    Immunoprecipitation and Western blot analysis detected p53 in lysates from G6 mTR−/− testis, but not in lysates from age-matched mTR+/+ testis or from G6 mTR−/− p53−/− littermate controls.

    “Immunoprecipitation and Western blot analysis readily detected p53 in lysates from G6 mTR−/− testis, but not in lysates derived from age-matched mTR+/+ testis or from G6 mTR−/− p53−/− littermate controls (Figure 1A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingcitation
    § Results

    The induction of p53 coincides with a dramatic increase in apoptosis and decreased cellularity in the G6 mTR−/− testis.

    “This induction of p53 coincides with the dramatic increase in apoptosis (as assessed by TUNEL) and decreased cellularity in the G6 mTR−/− testis (Lee et al. 1998”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Lee et al. 1998 source

      Not checked in the free run.

  • May combine two claims.

    Findingreasoning
    § Discussion

    Loss of p53 rescues the cell cycle arrest in MEFs and the apoptotic elimination of male germ cells.

    “Significantly, loss of p53 rescues the cell cycle arrest in MEFs and the apoptotic elimination of male germ cells.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.
  • The quote only partly states this claim.

    Findingown data
    § Abstract

    Loss of p53 abrogated the cell cycle block in G6 mTR−/− MEFs.

    “loss of p53 abrogated this block.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data
    § Abstract

    15% of G4-G6 mTR−/− mice (86 out of 565) were p53−/− compared to 26% of G7-G8 mTR−/− mice (24 of 91) (p = 0.015).

    “Significantly, 15% of the G4–G6 mTR−/− mice (86 out of 565 mice) were p53−/− compared to 26% of the G7–G8 mTR−/− mice (24 of 91 mice) (p = 0.015 by Fisher’s two-sided t test) (Figure 1E).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data
    § Abstract

    G6 mTR−/− p53−/− MEFs exhibited 1.65 (SD 2.59) fusions per metaphase, a 3-fold increase (p = 0.012).

    “By comparison, G6 mTR−/− p53−/− MEFs exhibited 1.65 (SD 2.59) fusions per metaphase, a 3-fold increase (p = 0.012).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data
    § Discussion

    In MEFs, the cell cycle arrest occurs with stabilization and activation of p53 protein, evident in p53-dependent reporter assays and activation of p21CIP1/WAF1.

    “In the case of MEFs, this arrest occurs in concert with the stabilization and activation of the p53 protein, evident in p53-dependent reporter assays and activation of p21CIP1/WAF1.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data
    § Abstract

    Similar differences in subcloning efficiency were observed in low-density seeding experiments.

    “Similar differences were observed in low-density seeding experiments (data not shown).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation
    § Introduction

    In human cells, a critical telomere length is eventually reached that induces cellular senescence, limiting the replicative capacity of cultured cells at the Hayflick limit.

    “In human cells, a critical telomere length is eventually reached that induces cellular senescence, thus limiting the replicative capacity of cultured cells at the Hayflick limit (Hayflick and Moorhead 1961”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Hayflick and Moorhead 1961 source

      Not checked in the free run.

  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation
    § Introduction

    In primary cells deficient for Rb and p53, continued cellular growth beyond the Hayflick limit results in severe telomere shortening, marked genetic instability, and massive cell death-a period referred to as crisis.

    “In primary cells deficient for Rb and p53, continued cellular growth beyond the Hayflick limit results in severe telomere shortening, marked genetic instability, and massive cell death—a period referred to as crisis (Counter et al. 1992”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Counter et al. 1992 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation
    § Introduction

    Ectopically expressed hTERT maintains telomere length and allows unlimited growth.

    “Ectopically expressed hTERT maintains telomere length and allows unlimited growth (Bodnar et al. 1998; Counter et al. 1998; Vaziri and Benchimol 1998”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites Bodnar et al. 1998 source

      Not checked in the free run.

    • cites Counter et al. 1998 source

      Not checked in the free run.

    • cites Vaziri and Benchimol 1998 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § Abstract

    Telomere function may be required for immortalization, supported by frequent activation of telomerase or ALT in human cancers.

    “The notion that telomere function may indeed be required for immortalization is supported by the frequent activation of telomerase or ALT in human cancers (Kim et al. 1994; Bryan et al. 1995”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Kim et al. 1994 source

      Not checked in the free run.

    • cites Bryan et al. 1995 source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisecitation
    § Introduction

    The telomere signal that activates the senescent program operates through the RB and p53 pathways.

    “The telomere signal that activates this senescent program operates through the RB and p53 pathways, since cell division beyond the Hayflick limit can occur after antisense neutralization (Hara et al. 1991”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Hara et al. 1991 source

      Not checked in the free run.

    • cites Shay et al. 1991 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Introduction

    Telomerase is comprised of essential catalytic (TERT) and RNA components (TR).

    “Telomerase is comprised of essential catalytic (telomerase reverse transcriptase [TERT]) and RNA components (telomerase RNA [TR]) (reviewed in Greider 1998”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Greider 1998 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § Abstract

    As mTR−/− mice advance with age and generation, an increase in cancer incidence is observed presumably due to increased genetic instability caused by telomere shortening, repeated chromosomal fusion-bridge-breakage cycles, and chromosomal loss.

    “Strikingly, as mTR−/− mice advance with age and generation, an increase in cancer incidence is observed presumably due to increased genetic instability caused by telomere shortening, repeated chromosomal fusion-bridge-breakage cycles, and chromosomal loss (Rudolph et al. 1999”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Rudolph et al. 1999 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § Abstract

    Due to the very long telomeres of Mus musculus, critical reduction in telomere length and chromosomal instability is only seen following extensive passage of mTR−/− cells, after successive generations of mTR−/− mice, or in aged mTR−/− organs with high proliferative histories.

    “Due to the very long telomeres of Mus musculus, critical reduction in telomere length and chromosomal instability is only seen following extensive passage of mTR−/− cells (Niida et al. 1998”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites Niida et al. 1998 source

      Not checked in the free run.

    • cites Blasco et al. 1997 source

      Not checked in the free run.

    • cites Lee et al. 1998 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Introduction

    The RNA subunit provides the template for telomere repeat synthesis.

    “The RNA subunit provides the template for telomere repeat synthesis (Greider and Blackburn 1989; Yu et al. 1990”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites Greider and Blackburn 1989

      Not checked in the free run.

    • cites Yu et al. 1990

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Introduction

    Immortalization of some epithelial cells requires not only TERT expression but also compromise of the RB pathway.

    “although immortalization of some epithelial cells requires not only TERT expression but also compromise of the RB pathway (Kiyono et al. 1998”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Kiyono et al. 1998 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data
    § Discussion

    Although loss of telomere and p53 function facilitates initiation of transformation, reconstitution of telomerase activity greatly improved the capacity of transformed foci to yield immortal cultures.

    “Although loss of telomere and p53 function facilitates initiation of transformation, the reconstitution of telomerase activity greatly improved the capacity of transformed foci to yield immortal cultures.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data
    § Abstract

    Telomere shortening or associated chromosome fusions and breakage rather than telomerase deficiency per se signals to p53 and accounts for p21CIP1/WAF1 induction.

    “Because G2 mTR−/− and G6 mTR−/− MEFs both lack telomerase activity, we conclude that telomere shortening or associated chromosome fusions and breakage rather than telomerase deficiency per se signals to p53 and accounts for p21CIP1/WAF1 induction.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning
    § Discussion

    The rampant genetic instability of G7 and G8 mTR−/− p53−/− cells is associated with loss of cell viability despite p53 deficiency, implying that advanced genomic catastrophe gives way to a p53-independent process.

    “Thus, the rampant genetic instability of the G7 and G8 mTR−/− p53−/− cells is associated with loss of cell viability despite p53 deficiency, implying that advanced genomic catastrophe gives way to a p53-independent process.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.
  • May combine two claims.

    Interpretationown data
    § Abstract

    Telomere dysfunction acts synergistically with p53 deficiency to initiate malignant transformation, presumably by enhancing genetic instability.

    “These results indicate that telomere dyfunction acts synergistically with p53 deficiency to initiate malignant transformation, presumably by enhancing genetic instability.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning
    § Abstract

    Continued proliferation in the absence of the p53 checkpoint may lead to an increased loss of telomere sequences and account for the increased frequency of chromosome fusions.

    “Continued proliferation in the absence of the p53 checkpoint may lead to an increased loss of telomere sequences and therefore account for the increased frequency of chromosome fusions.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning
    § Abstract

    p53 status was maintained in the heterozygous state to avoid potential broad genomic effects arising from p53 deficiency.

    “For these matings, the p53 status was maintained in the heterozygous state to avoid potential broad genomic effects arising from p53 deficiency.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data
    § Discussion

    The ability of exogenous telomerase to reduce focus formation in p53 null cells with short dysfunctional telomeres suggests that genetic instability associated with telomere loss can serve as an engine driving initiation of transformation, but only in the absence of functional p53.

    “The ability of exogenous telomerase to reduce focus formation in p53 null cells with short dysfunctional telomeres suggests that genetic instability associated with telomere loss can serve as an engine driving initiation of transformation, but only in the absence of functional p53 (Figure 5).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Focus formation reflects the earliest stages of oncogenic transformation.
  • May combine two claims.

    Interpretationreasoning
    § Discussion

    Early crisis accounts for efficient germ cell depletion in G6 mTR−/− p53+/+, whereas altered histology of G7 and G8 mTR−/− p53−/− testis provides experimental support for late crisis.

    “Early crisis accounts for efficient germ cell depletion in G6 mTR−/− p53+/+, whereas the altered histology of G7 and G8 mTR−/− p53−/− testis provides experimental support for late crisis.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.
  • May combine two claims.

    Interpretationown data
    § Abstract

    p53 deficiency restores neither telomere length nor function in the telomerase-deficient mouse.

    “Together, these data indicate that p53 deficiency restores neither telomere length nor function in the telomerase-deficient mouse.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning
    § Abstract

    The mating scheme produced p53+/+ and p53−/− littermate controls for each mTR−/− generation.

    “This mating scheme also produced p53+/+ and p53−/− littermate controls for each mTR−/− generation.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation
    § Abstract

    Telomere shortening in mTR−/− mice results in loss of telomere function and chromosome end-to-end fusion.

    “Telomere shortening in mTR−/− mice results in loss of telomere function and chromosome end-to-end fusion (Blasco et al. 1997; Rudolph et al. 1999”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Blasco et al. 1997 source

      Not checked in the free run.

    • cites Rudolph et al. 1999 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data
    § Discussion

    mTR expression facilitates subcloning efficiency of Myc/RAS-transformed late-generation mTR−/− cells, supporting the importance of telomere maintenance mechanisms during later stages of carcinogenesis.

    “The observation that mTR expression facilitates subcloning efficiency of Myc/RAS-transformed late-generation mTR−/− cells supports the importance of telomere maintenance mechanisms during later stages of carcinogenesis.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Abstract

    Induction of double strand breaks in DNA by ionizing radiation or genotoxic chemotherapy leads to rapid stabilization of p53 through phosphorylation of its N terminus.

    “Induction of double strand breaks in DNA by ionizing radiation or genotoxic chemotherapy leads to the rapid stabilization of p53 through phosphorylation of its N terminus (Shieh et al. 1997; Siliciano et al. 1997”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites Shieh et al. 1997 source

      Not checked in the free run.

    • cites Siliciano et al. 1997 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning
    § Discussion

    During the early stages of tumorigenesis, cells suffer telomere shortening, and telomerase activation is advantageous primarily in later stages of tumorigenesis.

    “Together with previous work, our data indicated that, first, during the early stages of tumorigenesis, cells suffer telomere shortening, and second, that telomerase activation is advantageous primarily in later stages of tumorigenesis.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Many human tumors that are telomerase positive still have short telomeres.
  • May combine two claims.

    Interpretationreasoning
    § Abstract

    Cells with short telomeres and intact p53-mediated DNA damage responses may be more efficiently culled from the population, therefore p53 null cells may accumulate more end-to-end fusions than their p53+/+ counterparts.

    “Cells with short telomeres and intact p53-mediated DNA damage responses may be more efficiently “culled” from the population (via apoptosis or arrest); therefore, p53 null cells may accumulate more end-to-end fusions than their p53+/+ counterparts.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning
    § Discussion

    Once both telomere function and p53 have been impaired, the fate of the cell is unpredictable and depends on other stochastic genetic changes.

    “Once both telomere function and p53 have been impaired, the fate of the cell is unpredictable and depends on other stochastic genetic changes.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation
    § Abstract

    p53 stabilization results in either cell cycle arrest via transcriptional induction of the p21CIP1/WAF1 CDK inhibitor or apoptosis.

    “This stabilization results in either cell cycle arrest via transcriptional induction of the p21CIP1/WAF1 CDK inhibitor or apoptosis (reviewed in Levine 1997”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Levine 1997 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning
    § Discussion

    Loss of p53 can circumvent the early crisis checkpoint, leading eventually to p53-independent apoptosis, perhaps as a consequence of uncontrolled chromosome fusion-bridge-breakage cycles and progressive genomic instability.

    “Loss of p53 can circumvent this checkpoint, leading eventually to p53-independent apoptosis, perhaps as a consequence of uncontrolled chromosome fusion-bridge-breakage cycles and progressive genomic instability.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data
    § Abstract

    Both the apoptotic response and cell cycle arrest induced by telomere dysfunction are mediated by p53.

    “Thus, both the apoptotic response and cell cycle arrest induced by telomere dysfunction are mediated by p53.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given
    § Discussion

    For telomere length determination of MEFs, littermate MEF cultures were assayed simultaneously to reduce experimental variability.

    “For telomere length determination of MEFs, littermate MEF cultures were assayed simultaneously to reduce experimental variability.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Discussion

    At least two independent determinations of the same cultures were performed for telomere length.

    “At least two independent determinations of the same cultures were performed.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given
    § Discussion

    Day to day variations in the linearity of the flow cytometer were controlled by the use of FITC-labeled fluorescence beads.

    “Day to day variations in the linearity of the flow cytometer were controlled by the use of FITC-labeled fluorescence beads (Flow Cytometry Standards Corporation).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given
    § Discussion

    For primary thymocytes, three independent age-matched sets of animals were used.

    “Three independent age-matched sets of animals were used.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning
    § Discussion

    In mTR−/− INK4a−/− mice, telomere dysfunction likely activates p53 via a DNA damage signaling pathway and results in growth arrest or apoptosis, limiting the efficiency of carcinogenesis.

    “In mTR−/− INK4a−/− mice, it is likely that telomere dysfunction activates p53 via a DNA damage signaling pathway and results in growth arrest or apoptosis, limiting the efficiency of carcinogenesis”
    Quote in the paperSubstantial claim
49 of 49
  • The paper relies on this without support.

    The signals and pathways mediating the cellular responses associated with telomere dysfunction have yet to be defined in mammalian cells.

    “The signals and pathways mediating these cellular responses associated with telomere dysfunction have yet to be defined in mammalian cells.”
  • The paper relies on this without support.

    The RAD9 and MEC1 DNA damage response pathways in yeast are similar to the p53 checkpoint in mammalian cells.

    “The RAD9 and MEC1 DNA damage response pathways in yeast are thought to be similar to the p53 checkpoint in mammalian cells.”
  • The paper relies on this without support.

    The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.

    “The mTR−/− mouse serves as a model to study the consequences of telomere loss in vivo.”
  • The paper relies on this without support.

    Focus formation reflects the earliest stages of oncogenic transformation.

    “Focus formation is thought to reflect the earliest stages of oncogenic transformation.”
  • The paper relies on this without support.

    Human cells require inactivation of Rb and/or p53 to bypass the major checkpoint that limits replicative lifespan: cellular senescence.

    “Human cells require inactivation of Rb and/or p53 to bypass the major checkpoint that limits replicative lifespan: cellular senescence.”
  • The paper relies on this without support.

    Rb/p53 inactivation allows continued cell division beyond senescence, progressive telomere shortening, and entry into crisis, from which only rare survivors emerge.

    “Rb/p53 inactivation allows continued cell division beyond senescence, progressive telomere shortening, and entry into crisis, from which only rare survivors will emerge.”
  • The paper relies on this without support.

    Many human tumors that are telomerase positive still have short telomeres.

    “The fact that many human tumors that are telomerase positive still have short telomeres supports the idea that telomerase activation occurs late in tumorigenesis.”
7 of 7

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • mTerc-/- p53 mutant mice experience a dramatic increase in cancer incidence, a shift in tumor spectrum toward epithelial cancers, and accumulation of marked chromosomal aberrations targeting cancer-relevant loci.

    “Although enabling cellular growth and survival and masking degenerative phenotypes, these mTerc -/ -p53 mutant mice experience a dramatic increase in cancer incidence, shift in tumor spectrum toward epithelial cancers, and accumulation of marked chromosomal aberrations targeting cancerrelevant loci for amplification and deletion (4-6).”

    From <i>Ink4a</i> / <i>Arf</i> tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [4]

    In the section on tumorigenic initiation and progression (page unavailable), the paper reports a threefold increase in chromosome fusions in mTR−/− p53−/− mouse embryo fibroblasts; the Discussion also reports that telomere dysfunction and p53 deficiency facilitate cellular transformation. These findings do not establish the claimed dramatic increase in cancer incidence or shift toward epithelial cancers in the mice, nor do the passages identify aberrations targeting specific cancer-relevant loci for amplification or deletion. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • p53 deficiency in mTerc-/- mice results in near-complete rescue of adverse cellular consequences associated with telomere dysfunction, including cellular growth arrest and apoptosis, progressive organ system atrophy, and physiological compromise.

    “Specifically, p53 deficiency results in nearcomplete rescue of adverse cellular consequences associated with telomere dysfunction, including cellular growth arrest and apoptosis, progressive organ system atrophy, and physiological compromise.”

    From <i>Ink4a</i> / <i>Arf</i> tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [4]

    The Abstract (page unavailable) says p53 deletion significantly attenuated the cellular and organismal effects of telomere dysfunction, but only during the earliest stages of genetic crisis. The testis findings (page unavailable) show near-normal size and markedly reduced apoptosis in some generations, while G7–G8 p53-deficient mice still showed significant germ-cell depletion. Thus the unqualified claim of near-complete rescue across the listed consequences overstates the paper. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Telomere dysfunction appears to engage the p53-dependent double-stranded break DNA damage pathway.

    “Telomere dysfunction appears to engage the p53-dependent double-stranded break DNA damage pathway.”

    From <i>Ink4a</i> / <i>Arf</i> tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [4]

    The Discussion ('Telomere Dysfunction Activates a p53-Dependent Checkpoint'; page not provided) says telomere loss activates a p53-dependent response similar to DNA-damage checkpoints. The paper also describes p53 stabilization after double-strand breaks, but does not establish that telomere dysfunction engages that specific double-strand-break pathway. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • When the p53 checkpoint is compromised, unchecked genomic instability caused by telomere dysfunction accelerates tumorigenesis as seen in late-generation mTerc-/- p53 mutant mice.

    “When the p53 checkpoint is compromised, unchecked genomic instability caused by telomere dysfunction accelerates tumorigenesis as seen in late-generation mTerc -/ -p53 mutant mice (4, 5).”

    From <i>Ink4a</i> / <i>Arf</i> tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [4]

    The section headed “Tumorigenic Initiation and Progression in the Setting of Telomere Dysfunction and p53 Deficiency” reports that telomere dysfunction and p53 deficiency cooperated to initiate malignant transformation in fibroblasts from late-generation mTR−/− p53−/− mice. It describes enhanced genetic instability as a presumed mechanism. It does not establish accelerated tumorigenesis in the mice themselves; its tumorigenesis evidence comes from a Myc/RAS transformation assay. Page numbers are unavailable in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • In mice, p53 inactivation alone is sufficient to avoid telomere-induced senescence and apoptosis.

    “By contrast, p53 inactivation alone is sufficient to avoid telomere-induced senescence and apoptosis in mice49,50.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A.
Affiliations
  • Harvard University (US)
  • Dana-Farber Cancer Institute (US)
  • Quest Diagnostics (United States) (US)
  • Johns Hopkins University (US)
Corresponding author
DePinho, Ronald A
Venue
Cell
Publisher
Elsevier BV
Published
1999-05
Volume
97
Issue
4
Pages
527-538
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2027779909
Cited by
979
References
44
Citations by year
2026: 10 · 2025: 12 · 2024: 18 · 2023: 21 · 2022: 15 · 2021: 22 · 2020: 15 · 2019: 26 · 2018: 24 · 2017: 23 · 2016: 32 · 2015: 34 · 2014: 23 · 2013: 40 · 2012: 51
FWCI
36.05
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01hd028317-05, 5r01hd034880-04, 5k08ar002104-04)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (K08AR02104-01)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD34880, R01 HD28317)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
p53, telomere dysfunction, telomere shortening, telomerase deficiency, telomere crisis, carcinogenesis, genomic instability, tumor suppression, apoptosis, growth arrest, telomere length
MeSH terms
Animals, Male, Mice, Inbred C57BL, Neoplasms, Phenotype, Spermatozoa, Testis, Tumor Suppressor Protein p53, Telomere, Apoptosis, Telomerase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review